Synapse Open Synapse
Biology

New Graft-versus-Host Disease treatments: What’s in the biotech pipeline in 2026?

Labiotech.eu · · 9 min read

Over the past decade, a succession of new GvHD treatments targeting different components of the immune response have been approved.

Latest from Labiotech.eu